<DOC>
	<DOCNO>NCT02728193</DOCNO>
	<brief_summary>The aim study elucidate difference rate complication , hospitalization day , medical expense , MRI show degree tumor necrosis , overall survival rate therapy PEI , MVA RFA , make standard minimally invasive treatment early stage HCC .</brief_summary>
	<brief_title>Standard Treatments Very-early Stage Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Preoperative clinical , image tumor marker diagnose hepatocellular carcinoma 2 . Tumor diameter &lt; 2cm 3 . ChildPugh class A liver function 4 . Without major organ dysfunction 5. male female patient &gt; 18 year &lt; =70 year age 6 . Voluntary participation clinical trial 1 . Other anticancer treatment therapy 2 . Patients apparent major organ ( i.e . cardiac , pulmonary , cerebral renal ) dysfunction , may affect treatment liver cancer 3 . Patients disease may affect treatment treatment 4 . History malignant tumor 5 . Patients participate clinical trial 6 . Pregnant , lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>treatment</keyword>
	<keyword>hepatocellular carcinoma</keyword>
</DOC>